A personalized mRNA vaccine has exhibited potential in the treatment of pancreatic cancer

This commentary discusses a ground-breaking study on the use of personalized mRNA cancer vaccines for treating pancreatic ductal adenocarcinoma (PDAC), a highly malignant form of cancer. The study, which capitalizes on lipid nanoparticles for mRNA vaccine delivery, aims to induce an immune response...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Ning, Zhang, Si, Wang, Yuzhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248956/
https://www.ncbi.nlm.nih.gov/pubmed/37323470
http://dx.doi.org/10.1007/s44178-023-00042-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248956/
https://www.ncbi.nlm.nih.gov/pubmed/37323470
http://dx.doi.org/10.1007/s44178-023-00042-z

Ejemplares similares